Indications and uses
Veterinary Lactated Ringer's Injection, USP is indicated as a source of water and electrolytes or as an alkalinizing agent.
Veterinary Lactated Ringer's Injection, USP is indicated as a source of water and electrolytes or as an alkalinizing agent.
As directed by a veterinarian. Dosage is dependent upon the age, weight and clinical condition of the patient, as well as laboratory determinations. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit. All solutions for injection contained in plastic containers are intended for administration using sterile equ...
For Animal Use Only
Veterinary Lactated Ringer's Injection, USP is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment in single dose containers for parenteral administration. It contains no antimicrobial agents.
| Composition (mg/100mL) | Ionic Concentration (mEq/L) | kcal/L | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Size (mL) | Sodium Chloride, USP (NaCl) | Sodium Lactate, USP (C3H5NaO3) | Potassium Chloride, USP (KCl) | Calcium Chloride, USP (CaCl2∙ 2H2O) | Osmolarity (mOsmol/L) (Calculated) | pH | Sodium | Potassium | Calcium | Chloride | Lactate | Caloric Content |
| 250 | 600 | 310 | 30 | 20 | 273 | 6.5 (6.0 to 7.5) | 130 | 4 | 2.7 | 109 | 28 | 9 |
| 500 | ||||||||||||
| 1000 | ||||||||||||
Veterinary Lactated Ringer's Injection, USP has value as a source of water and electrolytes. It is capable of inducing diuresis depending on the clinical condition of the patient.
Veterinary Lactated Ringer's Injection, USP produces a metabolic alkalinizing effect. Lactate ions are metabolized ultimately to carbon dioxide and water, which requires the consumption of hydrogen cations.
Veterinary Lactated Ringer's Injection, USP is indicated as a source of water and electrolytes or as an alkalinizing agent.
Do not administer to horses by intraperitoneal injection.
Veterinary Lactated Ringer's Injection, USP should be used with great care, if at all, in patients with congestive heart failure, severe renal insufficiency, and in clinical states in which there exists edema with sodium retention.
Veterinary Lactated Ringer's Injection, USP should be used with great care, if at all, in patients with hyperkalemia, severe renal failure, and in conditions in which potassium retention is present.
Veterinary Lactated Ringer's Injection, USP should be used with great care in patients with metabolic or respiratory alkalosis. The administration of lactate ions should be done with great care in those conditions in which there is an increased level or an impaired utilization of these ions, such as severe hepatic insufficiency.
Veterinary Lactated Ringer's Injection, USP should not be administered simultaneously with blood through the same administration set because of the likelihood of coagulation.
The parenteral administration of Veterinary Lactated Ringer's Injection, USP can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states, or pulmonary edema. The risk of dilutional states is inversely proportional to the electrolyte concentrations of the injections. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of the injections.
In patients with diminished renal function, administration of Veterinary Lactated Ringer's Injection, USP may result in sodium or potassium retention.
Veterinary Lactated Ringer's Injection, USP is not for use in the treatment of lactic acidosis.
Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation, and hypervolemia. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures, and save the remainder of the fluid for examination if deemed necessary.
Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations, and acid base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation. Veterinary Lactated Ringer's Injection, USP must be used with caution. Excess administration may result in metabolic alkalosis. Caution must be exercised in the administration of Veterinary Lactated Ringer's Injection, USP to patients receiving corticosteroids or corticotropin. Do not administer unless solution is clear and seal is intact.
As directed by a veterinarian. Dosage is dependent upon the age, weight and clinical condition of the patient, as well as laboratory determinations. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.
All solutions for injection contained in plastic containers are intended for administration using sterile equipment and aseptic technique. Additives may be incompatible. Complete information is not available. Those additives known to be incompatible should not be used. Consult with pharmacist, if available. If, in the informed judgment of the veterinarian, it is deemed advisable to introduce additives, use aseptic technique. Mix thoroughly when additives have been introduced. Do not store solutions containing additives. Discard unused portion.
In an event of overhydration or solute overload, re-evaluate the patient and institute appropriate corrective measures. See Warnings, Adverse Reactions and Precautions.
Veterinary Lactated Ringer's Injection, USP is supplied in plastic bags as follows:
The plastic container is fabricated from a multi-layer, Polyolefin/Styrene-block copolymer film. The amount of water that can permeate from inside the container into the overwrap is insufficient to affect the solution significantly.
STORAGE: Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. It is recommended the product be stored in the moisture barrier overwrap at room temperature (25°C/77°F); brief exposure up to (40°C/104°F) does not adversely affect the product.
Tear overwrap down side at slit and remove solution bag. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually. Check for minute leaks by squeezing inner bag firmly. If leaks are found, discard solution as sterility may be impaired. If supplemental medication is desired, follow directions below.
WARNING: Additives may be incompatible.
To add medication before solution administration
To add medication during solution administration
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 847630 | lactated Ringers Injectable Solution | PSN | 4 |
| 847630 | calcium chloride 0.2 MG/ML / potassium chloride 0.3 MG/ML / sodium chloride 6 MG/ML / sodium lactate 3.1 MG/ML Injectable Solution | SCD | 4 |
| 847630 | calcium chloride 0.2 MG/ML / K+ chloride 0.3 MG/ML / NaCl 6 MG/ML / sodium lactate 3.1 MG/ML Injectable Solution | SY | 4 |
| 847630 | calcium chloride 0.2 MG/ML / Pot chloride 0.3 MG/ML / NaCl 6 MG/ML / sodium lactate 3.1 MG/ML Injectable Solution | SY | 4 |
| 847630 | calcium chloride 20 MG / potassium chloride 30 MG / sodium chloride 600 MG / sodium lactate 310 MG per 100 ML Ringer's Injectable Solution | SY | 4 |
| Class | Version | Type | Effective |
|---|---|---|---|
| SODIUM CATION Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83155-202-10 | Veterinary Lactated Ringers | 1000 mL in 1 CONTAINER | INJECTION, SOLUTION | 1000 | 4 | |
| 83155-202-25 | Veterinary Lactated Ringers | 250 mL in 1 CONTAINER | INJECTION, SOLUTION | 250 | 4 | |
| 83155-202-50 | Veterinary Lactated Ringers | 500 mL in 1 CONTAINER | INJECTION, SOLUTION | 500 | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 83155-202 | 83155-202-25, 83155-202-50, 83155-202-10 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| sodium lactate | TU7HW0W0QT | ACTIB |
| sodium chloride | 451W47IQ8X | ACTIB |
| potassium chloride | 660YQ98I10 | ACTIB |
| calcium chloride | M4I0D6VV5M | ACTIB |
| Water | 059QF0KO0R | IACT |
Adverse event summaries are temporarily unavailable. Other product information remains available.